Neurobiology of Aging
Volume 30, Issue 9 , Pages 1420-1429 , September 2009

Right prefrontal hypometabolism predicts delusions in dementia with Lewy bodies

  • Robert Perneczky

      Affiliations

    • Department of Psychiatry and Psychotherapy, Technical University Munich, Ismaninger Str. 22, 81675 München, Germany
    • Corresponding Author InformationCorresponding author at: Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München, Ismaninger Str. 22, 81675 München, Germany. Tel.: +49 89 4140 4279; fax: +49 89 4140 4923.
    • ,
  • Alexander Drzezga

      Affiliations

    • Department of Nuclear Medicine, Technical University Munich, Ismaninger Str. 22, 81675 München, Germany
    • ,
  • Henning Boecker

      Affiliations

    • Department of Nuclear Medicine, Technical University Munich, Ismaninger Str. 22, 81675 München, Germany
    • Department of Radiology, Rheinische Friedrich-Wilhelms-Universität Bonn, Sigmund-Freud-Str. 25, 53127 Bonn, Germany
    • ,
  • Stefan Wagenpfeil

      Affiliations

    • Institute of Medical Statistics and Epidemiology, Technical University Munich, Ismaninger Str. 22, 81675 München, Germany
    • ,
  • Hans Förstl

      Affiliations

    • Department of Psychiatry and Psychotherapy, Technical University Munich, Ismaninger Str. 22, 81675 München, Germany
    • ,
  • Alexander Kurz

      Affiliations

    • Department of Psychiatry and Psychotherapy, Technical University Munich, Ismaninger Str. 22, 81675 München, Germany
    • ,
  • Peter Häussermann

      Affiliations

    • Department of Neurology, Technical University Munich, Ismaninger Str. 22, 81675 München, Germany
    • Centre for Integrative Psychiatry, Niemannsweg 147, 24105 Kiel, Germany

Received 10 August 2007 ,Revised 26 November 2007 ,Accepted 3 December 2007.

References 

  1. Ballard C, Grace J, McKeith I, Holmes C. Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease. Lancet. 1998;351:1032–1033
  2. Ballard C, Holmes C, McKeith I, Neill D, O’Brien J, Cairns N, et al. Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease. Am. J. Psychiatry. 1999;156:1039–1045
  3. Ballard CG, Jacoby R, Del Ser T, Khan MN, Munoz DG, Holmes C, et al. Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies. Am. J. Psychiatry. 2004;161:843–849
  4. Boecker H, Ceballos-Baumann AO, Volk D, Conrad B, Forstl H, Haussermann P. Metabolic alterations in patients with Parkinson disease and visual hallucinations. Arch. Neurol. 2007;64:984–988
  5. Burruss JW, Hurley RA, Taber KH, Rauch RA, Norton RE, Hayman LA. Functional neuroanatomy of the frontal lobe circuits. Radiology. 2000;214:227–230
  6. Chandler MJ, Lacritz LH, Hynan LS, Barnard HD, Allen G, Deschner M, et al. A total score for the CERAD neuropsychological battery. Neurology. 2005;65:102–106
  7. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308–2314
  8. Davis CE, Jeste DV, Eyler LT. Review of longitudinal functional neuroimaging studies of drug treatments in patients with schizophrenia. Schizophr. Res. 2005;78:45–60
  9. de Vugt ME, Riedijk SR, Aalten P, Tibben A, van Swieten JC, Verhey FR. Impact of behavioural problems on spousal caregivers: a comparison between Alzheimer's disease and frontotemporal dementia. Dement. Geriatr. Cogn. Disord. 2006;22:35–41
  10. Diehl-Schmid J, Grimmer T, Drzezga A, Bornschein S, Riemenschneider M, Forstl H, et al. Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study. Neurobiol. Aging. 2007;28:42–50
  11. Drzezga A, Riemenschneider M, Strassner B, Grimmer T, Peller M, Knoll A, et al. Cerebral glucose metabolism in patients with AD and different APOE genotypes. Neurology. 2005;64:102–107
  12. Fahn S, Elton RL Members of the UPDRS Development Committee. Unified Parkinsons's disease rating scale. In:  Fahn S,  Marsden CD,  Calne CD,  Goldstein M editor. Recent Developments in Parkinson's Disease. vol. II:Florham Park (NJ): Macmillan Healthcare Information; 1987;pp. 153–163, 293–304
  13. Fischer C, Bozanovic R, Atkins JH, Rourke SB. Treatment of delusions in dementia with Lewy bodies—response to pharmacotherapy. Dement. Geriatr. Cogn. Disord. 2007;23:307–311
  14. Fischer C, Ladowsky-Brooks R, Millikin C, Norris M, Hansen K, Rourke SB. Neuropsychological functioning and delusions in dementia: a pilot study. Aging Ment. Health. 2006;10:27–32
  15. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975;12:189–198
  16. Forstl H, Besthorn C, Geiger-Kabisch C, Sattel H, Schreiter-Gasser U. Psychotic features and the course of Alzheimer's disease: relationship to cognitive, electroencephalographic and computerized tomography findings. Acta Psychiatr. Scand. 1993;87:395–399
  17. Fox P, Lancaster J. Neuroscience on the net. Science. 1994;266:994–996
  18. Fusar-Poli P, Perez J, Broome M, Borgwardt S, Placentino A, Caverzasi E, et al. Neurofunctional correlates of vulnerability to psychosis. A systematic review and meta-analysis. Neurosci. Biobehav. Rev. 2007;31:465–484
  19. Geser F, Wenning GK, Poewe W, McKeith I. How to diagnose dementia with Lewy bodies: state of the art. Mov. Disord. 2005;20(Suppl. 12):S11–S20
  20. Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, et al. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology. 1990;40:1–8(comment)
  21. Herholz K, Salmon E, Perani D, Baron JC, Holthoff V, Frolich L, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage. 2002;17:302–316
  22. Higuchi M, Tashiro M, Arai H, Okamura N, Hara S, Higuchi S, et al. Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies. Exp. Neurol. 2000;162:247–256
  23. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry. 1992;55:181–184
  24. Ishii K, Imamura T, Sasaki M, Yamaji S, Sakamoto S, Kitagaki H, et al. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Neurology. 1998;51:125–130
  25. Kim JM, Shin IS, Jeong SJ, Gormley N, Yoon JS. Predictors of institutionalization in patients with dementia in Korea. Int. J. Geriatr. Psychiatry. 2002;17:101–106
  26. Kono AK, Ishii K, Soufe K, Miyamoto N, Sakamoto S, Mori E. Fully automatic differential diagnosis system for dementia with Lewy bodies and Alzheimer's disease using FDG-PET and 3D-SSP. Eur. J. Nucl. Med. Mol. Imaging. 2007;34:1490–1497
  27. Kotrla KJ, Chacko RC, Harper RG, Jhingran S, Doody R. SPECT findings on psychosis in Alzheimer's disease. Am. J. Psychiatry. 1995;152:1470–1475
  28. Kuzuhara S, Yoshimura M. Clinical and neuropathological aspects of diffuse Lewy body disease in the elderly. Adv. Neurol. 1993;60:464–469
  29. MacDonald AW, Carter CS, Kerns JG, Ursu S, Barch DM, Holmes AJ, et al. Specificity of prefrontal dysfunction and context processing deficits to schizophrenia in never-medicated patients with first-episode psychosis. Am. J. Psychiatry. 2005;162:475–484
  30. McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863–1872
  31. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113–1124
  32. McKhann G, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939–944
  33. Morris JC, Mohs RC, Rogers H, Fillenbaum G, Heyman A. Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol. Bull. 1988;24:641–652
  34. Nakano S, Yamashita F, Matsuda H, Kodama C, Yamada T. Relationship between delusions and regional cerebral blood flow in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2006;21:16–21
  35. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546–1554
  36. Perneczky R, Haussermann P, Diehl-Schmid J, Boecker H, Forstl H, Drzezga A, et al. Metabolic correlates of brain reserve in dementia with Lewy bodies: an FDG PET study. Dement. Geriatr. Cogn. Disord. 2007;23:316–322
  37. Perneczky R, Hartmann J, Grimmer T, Drzezga A, Kurz A. Cerebral metabolic correlates of the clinical dementia rating scale in mild cognitive impairment. J. Geriatr. Psychiatry Neurol. 2007;20:84–88
  38. Perneczky R, Wagenpfeil S, Komossa K, Grimmer T, Diehl J, Kurz A. Mapping scores onto stages: mini-mental state examination and clinical dementia rating. Am. J. Geriatr. Psychiatry. 2006;14:139–144
  39. Simard M, van Reekum R, Cohen T. A review of the cognitive and behavioral symptoms in dementia with Lewy bodies. J. Neuropsychiatry Clin. Neurosci. 2000;12:425–450
  40. Staff RT, Venneri A, Gemmell HG, Shanks MF, Pestell SJ, Murray AD. HMPAO SPECT imaging of Alzheimer's disease patients with similar content-specific autobiographic delusion: comparison using statistical parametric mapping. J. Nucl. Med. 2000;41:1451–1455
  41. Sultzer DL, Brown CV, Mandelkern MA, Mahler ME, Mendez MF, Chen ST, et al. Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer's disease. Am. J. Psychiatry. 2003;160:341–349
  42. Talairach J, Tournoux P. Co-planar stereotactical Atlas of the Human Brain: 3-Dimensional Proportional System—An Approach to Cerebral Imaging. New York: Thieme Medical Publishers; 1988;
  43. Thalmann B, Monsch AU CERAD. The Consortium to Establish a Registry for Alzheimer's Disease. Neuropsychologische Testbatterie. Basel: Memory Clinic Basel; 1997;
  44. van Straaten EC, Scheltens P, Barkhof F. MRI and CT in the diagnosis of vascular dementia. J. Neurol. Sci. 2004;226:9–12
  45. Volz HP, Gaser C, Hager F, Rzanny R, Mentzel HJ, Kreitschmann-Andermahr I, et al. Brain activation during cognitive stimulation with the Wisconsin Card Sorting Test–a functional MRI study on healthy volunteers and schizophrenics. Psychiatry Res. 1997;75:145–157

PII: S0197-4580(07)00464-2

doi: 10.1016/j.neurobiolaging.2007.12.001

Neurobiology of Aging
Volume 30, Issue 9 , Pages 1420-1429 , September 2009

Article Tools

* Image Usage & Resolution